This topic contains a solution. Click here to go to the answer

Author Question: A major component of the ICD-10 transition is: a. electronic transactions. b. use of a different ... (Read 22 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
A major component of the ICD-10 transition is:
 
  a. electronic transactions.
  b. use of a different reference manual.
  c. increased time to file medical records.
  d. reduced time with patients.

Question 2

A paper-reduction and time-saving process for medical billers related to the ICD-10 is:
 
  a. decreased need for claims attachment to clarify diagnosis.
  b. use of electronic methods.
  c. sending claims electronically versus mail.
  d. improved tracking of diagnosis changes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Smiles0805

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

Answer: a

Answer to Question 2

Answer: a




Alygatorr01285

  • Member
  • Posts: 564
Reply 2 on: Jun 27, 2018
:D TYSM


rachel

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Excellent

 

Did you know?

The cure for trichomoniasis is easy as long as the patient does not drink alcoholic beverages for 24 hours. Just a single dose of medication is needed to rid the body of the disease. However, without proper precautions, an individual may contract the disease repeatedly. In fact, most people develop trichomoniasis again within three months of their last treatment.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

There are actually 60 minerals, 16 vitamins, 12 essential amino acids, and three essential fatty acids that your body needs every day.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library